FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

FDA panel considers a first-of-its-kind flu vaccine using mRNA technology

U.S. health advisers are debating a new kind of flu vaccine.

Original Source

Read the full article at Seattletimes →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.